comparemela.com
Home
Live Updates
With FDA approval in hand, BioMarin lays out plan to sell $2
With FDA approval in hand, BioMarin lays out plan to sell $2
With FDA approval in hand, BioMarin lays out plan to sell $2.9M gene therapy
BioPharma
Related Keywords
Hank Fuchs ,
Jeff Ajer ,
Roche Hemlibra ,
Joseph Schwartz ,
Paul Matteis ,
Drug Administration ,
Schwartz ,
Biomarin Pharmaceutical ,